当前位置:首页 - 行情中心 - 星昊医药(430017) - 财务分析 - 现金流量表

星昊医药

(430017)

  

流通市值:24.49亿  总市值:24.67亿
流通股本:1.21亿   总股本:1.22亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金325,780,765.54160,486,306.67660,864,320.7499,687,176.68
  收到的税费返还2,076,270.2534,249.621,811,048.511,770,808.19
  收到其他与经营活动有关的现金15,985,085.334,696,005.7237,540,750.4733,557,481.44
  经营活动现金流入小计343,842,121.12165,216,562.01700,216,119.68535,015,466.31
  购买商品、接受劳务支付的现金61,103,389.7825,051,170.14127,564,332.993,216,477.82
  支付给职工以及为职工支付的现金52,144,183.4229,103,128.73105,438,808.2381,106,919.38
  支付的各项税费33,378,971.7713,106,728.3366,386,110.7647,773,847.21
  支付其他与经营活动有关的现金141,097,709.0771,700,918.29317,828,015.12212,645,321.66
  经营活动现金流出小计287,724,254.04138,961,945.49617,217,267.01434,742,566.07
  经营活动产生的现金流量净额56,117,867.0826,254,616.5282,998,852.67100,272,900.24
二、投资活动产生的现金流量:
  收回投资收到的现金454,030,000320,030,0002,056,000,0001,404,000,000
  取得投资收益收到的现金3,399,410.962,254,534.2411,378,670.038,932,011.81
  处置子公司及其他营业单位收到的现金净额---2,566,624.04-2,782,914.61
  收到的其他与投资活动有关的现金16,060,190.0516,060,190.053,554,269.4-
  投资活动现金流入小计473,489,601.01338,344,724.292,068,366,315.391,410,149,097.2
  购建固定资产、无形资产和其他长期资产支付的现金22,281,370.3310,987,291.1999,248,880.765,802,089.07
  投资支付的现金436,000,000341,000,0001,966,030,0001,531,030,000
  投资活动现金流出小计458,281,370.33351,987,291.192,065,278,880.71,596,832,089.07
  投资活动产生的现金流量净额15,208,230.68-13,642,566.93,087,434.69-186,682,991.87
三、筹资活动产生的现金流量:
  吸收投资收到的现金--0-
  取得借款收到的现金--10,010,00010,010,000
  收到其他与筹资活动有关的现金--0-
  筹资活动现金流入小计0010,010,00010,010,000
  偿还债务支付的现金--10,010,00010,000,000
  分配股利、利润或偿付利息支付的现金19,557,055.4870,00030,664,415.5430,593,623.14
  支付其他与筹资活动有关的现金--15,760,140.093,020,000
  筹资活动现金流出小计19,557,055.4870,00056,434,555.6343,613,623.14
  筹资活动产生的现金流量净额-19,557,055.48-70,000-46,424,555.63-33,603,623.14
四、汇率变动对现金及现金等价物的影响1,195,239.22372,529.56-608,569.09-19,803.93
五、现金及现金等价物净增加额52,964,281.512,914,579.1839,053,162.64-120,033,518.7
  加:期初现金及现金等价物余额413,929,487.39413,929,487.39374,876,324.75375,926,324.75
  期末现金及现金等价物余额466,893,768.89426,844,066.57413,929,487.39255,892,806.05
补充资料:
  净利润41,083,255.36-81,632,668.88-
  资产减值准备3,068,019.01-385,137.64-
  固定资产和投资性房地产折旧23,849,129.54-44,791,366.4-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧23,849,129.54-44,791,366.4-
  无形资产摊销2,707,531.75-7,263,118.6-
  长期待摊费用摊销68,807.34-250,791.84-
  固定资产报废损失--3,160.54-
  公允价值变动损失-2,276,969.84--3,860,704.13-
  财务费用-1,210,635.12-901,194.75-
  投资损失-1,300,088.96--10,808,052.19-
  递延所得税527,169.8-5,046,476.49-
  其中:递延所得税资产减少496,951.62-4,792,064.89-
    递延所得税负债增加30,218.18-254,411.6-
  存货的减少-4,349,529.71-3,003,731.08-
  经营性应收项目的减少13,929,068.77--22,690,412.22-
  经营性应付项目的增加-20,832,093.09--26,976,543.07-
  现金的期末余额466,893,768.89-413,929,487.39-
  减:现金的期初余额413,929,487.39-374,876,324.75-
  现金及现金等价物的净增加额52,964,281.5-39,053,162.64-
公告日期2025-08-082025-04-282025-04-232024-10-28
审计意见(境内)标准无保留意见
TOP↑